妊娠35-37周胎盘形成受损生物标志物对不良围产结局的预测
这项前瞻性观察研究纳入19 209例单胎妊娠,在35+0至36+6周测量子宫动脉搏动指数(UtA-PI)、胎盘生长因子(PlGF)和可溶性fms样酪氨酸激酶-1(sFlt-1),评估其对不良围产结局的预测价值。结果显示,UtA-PI、sFlt-1或PlGF对小于胎龄儿(SGA)和非SGA胎儿的不良围产结局预测均较差。
要点
- 83%的死产、82%的可疑胎儿窘迫剖宫产、91%的新生儿死亡或缺氧缺血性脑病及86%的新生儿病房住院≥48小时发生于非SGA新生儿。
- UtA-PI>95百分位、sFlt-1>95百分位和PlGF<5百分位与可疑胎儿窘迫剖宫产和新生儿病房住院≥48小时风险增加相关。
- 多变量logistic回归显示生物标志物对可疑胎儿窘迫剖宫产无显著贡献,对新生儿病房住院≥48小时的预测仅轻微改善。
核心结论
- 在35-37周常规产前评估的妊娠中,UtA-PI、sFlt-1或PlGF对SGA和非SGA胎儿的不良围产结局预测均较差。
研究设计与样本
- 前瞻性观察研究,纳入19 209例在35+0至36+6周进行常规医院访视的单胎妊娠。
主要发现
- 83%的死产、82%的可疑胎儿窘迫剖宫产、91%的新生儿死亡或缺氧缺血性脑病Grade 2或3及86%的新生儿病房住院≥48小时发生于非SGA新生儿。
- UtA-PI>95百分位、sFlt-1>95百分位和PlGF<5百分位与可疑胎儿窘迫剖宫产和新生儿病房住院≥48小时风险增加相关;死产和新生儿死亡或缺氧缺血性脑病病例数太少,无法显示与无这些不良结局病例的差异有统计学显著性。
- 多变量logistic回归分析显示,在预测可疑胎儿窘迫剖宫产时,生物标志物无显著贡献;母体人口学特征和病史对新生儿病房住院≥48小时的预测仅通过加入sFlt-1或PlGF而 marginal 改善。
- 对于每种生物标志物,SGA新生儿的不良结局检出率高于非SGA新生儿,但这一增加伴随假阳性率增加。
- UtA-PI>95百分位、sFlt-1>95百分位和PlGF<5百分位对大多数不良结局的相对风险在SGA和非SGA新生儿中均<2.5。
临床怎么用
- 原文未据此给出推荐。
局限性
- 死产和新生儿死亡或缺氧缺血性脑病病例数太少,无法显示与无这些不良结局病例的差异有统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the potential value of uterine artery pulsatility index (UtA-PI) and serum levels of the angiogenic placental growth factor (PlGF) and the antiangiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1) in the prediction of adverse perinatal outcome in small-for-gestational-age (SGA) and non-SGA neonates at 35-37 weeks' gestation. METHODS: This was a prospective observational study of 19 209 singleton pregnancies attending for a routine hospital visit at 35 + 0 to 36 + 6 weeks' gestation. This visit included recording of maternal demographic characteristics and medical history, sonographic estimation of fetal weight, color Doppler ultrasound for measurement of mean UtA-PI, and measurement of serum concentrations of PlGF and sFlt-1. Multivariable logistic regression analysis was carried out to determine which of the factors from maternal or pregnancy characteristics and measurements of UtA-PI, PlGF and sFlt-1 provided a significant contribution in the prediction of each of four adverse outcome measures: first, stillbirth; second, Cesarean delivery for suspected fetal compromise in labor; third, neonatal death or hypoxic ischemic encephalopathy Grade 2 or 3; and, fourth, admission to the neonatal unit (NNU) for ≥ 48 h. Predicted probabilities from logistic regression analysis were used to construct receiver-operating characteristics curves to assess the performance of screening for these adverse outcomes. RESULTS: First, 83% of stillbirths, 82% of Cesarean sections for presumed fetal compromise in labor, 91% of cases of neonatal death or hypoxic ischemic encephalopathy and 86% of NNU admissions for ≥ 48 h occurred in pregnancies with a non-SGA neonate. Second, UtA-PI > 95th percentile, sFlt-1 > 95th percentile and PlGF < 5th percentile were associated with increased risk of Cesarean delivery for suspected fetal compromise in labor and NNU admission for ≥ 48 h; the number of stillbirths and cases of neonatal death or hypoxic ischemic encephalopathy was too small to demonstrate significance in the observed differences from cases without these adverse outcomes. Third, multivariable logistic regression analysis demonstrated that, in the prediction of Cesarean delivery for suspected fetal compromise in labor, there was no significant contribution from biomarkers; the prediction of NNU admission for ≥ 48 h by maternal demographic characteristics and medical history was only marginally improved by the addition of sFlt-1 or PlGF. Fourth, for each biomarker, the detection rate of adverse outcome was higher in SGA than in non-SGA neonates, but this increase was accompanied by an increase in false-positive rate. Fifth, the relative risk of UtA-PI > 95th , sFlt-1 > 95th and PlGF < 5th percentiles for most adverse outcomes was < 2.5 in both SGA and non-SGA neonates. CONCLUSIONS: In pregnancies undergoing routine antenatal assessment at 35-37 weeks' gestation, measurements of UtA-PI, sFlt-1 or PlGF provide poor prediction of adverse perinatal outcome in both SGA and non-SGA fetuses. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Ciobanou A, Jabak S, De Castro H, et al. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol. 2019. PMID: 31100188. doi:10.1002/uog.20346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。